1. Home
  2. CDP vs FOLD Comparison

CDP vs FOLD Comparison

Compare CDP & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDP
  • FOLD
  • Stock Information
  • Founded
  • CDP 1988
  • FOLD 2002
  • Country
  • CDP United States
  • FOLD United States
  • Employees
  • CDP N/A
  • FOLD N/A
  • Industry
  • CDP Real Estate Investment Trusts
  • FOLD Biotechnology: Pharmaceutical Preparations
  • Sector
  • CDP Real Estate
  • FOLD Health Care
  • Exchange
  • CDP Nasdaq
  • FOLD Nasdaq
  • Market Cap
  • CDP 3.1B
  • FOLD 2.9B
  • IPO Year
  • CDP N/A
  • FOLD 2007
  • Fundamental
  • Price
  • CDP $28.70
  • FOLD $7.58
  • Analyst Decision
  • CDP Strong Buy
  • FOLD Strong Buy
  • Analyst Count
  • CDP 5
  • FOLD 10
  • Target Price
  • CDP $33.60
  • FOLD $26.89
  • AVG Volume (30 Days)
  • CDP 806.6K
  • FOLD 3.8M
  • Earning Date
  • CDP 10-27-2025
  • FOLD 07-31-2025
  • Dividend Yield
  • CDP 4.25%
  • FOLD N/A
  • EPS Growth
  • CDP N/A
  • FOLD N/A
  • EPS
  • CDP 1.27
  • FOLD N/A
  • Revenue
  • CDP $751,457,000.00
  • FOLD $571,160,000.00
  • Revenue This Year
  • CDP N/A
  • FOLD $20.98
  • Revenue Next Year
  • CDP $4.56
  • FOLD $20.74
  • P/E Ratio
  • CDP $22.57
  • FOLD N/A
  • Revenue Growth
  • CDP 3.13
  • FOLD 25.35
  • 52 Week Low
  • CDP $23.92
  • FOLD $5.51
  • 52 Week High
  • CDP $34.22
  • FOLD $12.65
  • Technical
  • Relative Strength Index (RSI)
  • CDP 60.87
  • FOLD 69.88
  • Support Level
  • CDP $28.56
  • FOLD $7.40
  • Resistance Level
  • CDP $29.08
  • FOLD $7.80
  • Average True Range (ATR)
  • CDP 0.41
  • FOLD 0.22
  • MACD
  • CDP 0.11
  • FOLD 0.01
  • Stochastic Oscillator
  • CDP 76.72
  • FOLD 87.61

About CDP COPT Defense Properties of Beneficial Interest

COPT Defense Properties is a fully-integrated and self-managed real estate investment trust (REIT) focused on owning, operating and developing properties in locations proximate to, or sometimes containing, key U.S. Government (USG) defense installations and missions. Its tenants include the USG and their defense contractors, who are engaged in priority national security activities, and who generally require mission-critical and high security property enhancements. Its properties include 195 operating properties totaling approximately 22.4 million square feet comprised of 16.5 million square feet in 164 office properties and 5.9 million square feet in 31 single-tenant data center shells.

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.

Share on Social Networks: